Free Trial

BioMarin Pharmaceutical (BMRN) SEC Filings & 10K Form

BioMarin Pharmaceutical logo
$72.03 -0.20 (-0.28%)
Closing price 03/10/2025 04:00 PM Eastern
Extended Trading
$72.04 +0.02 (+0.02%)
As of 03/10/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BioMarin Pharmaceutical SEC Filings

DateFilerForm TypeView
03/04/2025
3:11 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:15 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:17 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:19 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:18 PM
BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:21 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
12:54 PM
BioMarin Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
9:26 AM
BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:07 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
1:14 PM
BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
12/03/2024
5:15 PM
BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
1:44 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
1:27 PM
BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:01 PM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
3:50 PM
BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
3:51 PM
BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:29 PM
BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
09/24/2024
7:31 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:54 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
11:52 AM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
4:02 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:00 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
10:48 AM
BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
12:14 PM
BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
07/01/2024
3:19 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:28 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:29 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
9:18 AM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
5:28 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
9:49 AM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
5:18 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
1:22 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
9:10 AM
BioMarin Pharmaceutical (Subject)
LAWLIS V BRYAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
9:18 AM
BioMarin Pharmaceutical (Subject)
Mueller Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
9:28 AM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:36 AM
BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2024
4:23 PM
BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:26 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:30 PM
BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:33 PM
BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:34 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

05/23/2024
4:36 PM
BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:14 PM
BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:20 PM
BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:06 PM
ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:08 PM
BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:33 PM
BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2024
3:36 PM
BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
4:20 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:16 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
2:57 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
9:11 AM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
9:54 AM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
4:58 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:40 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:45 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
4:37 PM
BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
9:49 AM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/26/2024
12:59 PM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:07 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:11 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:21 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
2:07 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
8:49 AM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2024
8:54 AM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/09/2024
3:24 PM
BioMarin Pharmaceutical (Filer)
Form ARS
04/09/2024
3:07 PM
BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/09/2024
3:09 PM
BioMarin Pharmaceutical (Filer)
Form DEFA14A
03/20/2024
4:13 PM
BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:48 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:50 PM
BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:53 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:55 PM
BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:36 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:40 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:42 PM
BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:46 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:BMRN) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners